NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE148400 Query DataSets for GSE148400
Status Public on Apr 10, 2020
Title Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation(s) 32333502
Submission date Apr 09, 2020
Last update date May 25, 2020
Contact name Bernard Haendler
E-mail(s) bernard.haendler@bayer.com
Organization name Bayer AG
Department Preclinical Research
Lab Oncology
Street address Muellerstrasse 178
City Berlin
ZIP/Postal code 13343
Country Germany
 
Platforms (1)
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
Samples (219)
GSM4462676 AR_VCAP_Control_Rep1
GSM4462677 AR_VCAP_Control_Rep2
GSM4462678 AR_VCAP_Control_Rep3
This SuperSeries is composed of the following SubSeries:
GSE148358 Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation [ChIP-seq]
GSE148397 Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation [RNA-seq]
Relations
BioProject PRJNA624133

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE148400_RAW.tar 91.2 Mb (http)(custom) TAR (of NARROWPEAK)
SRA Run SelectorHelp
| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap